Previous studies have demonstrated that low-dose angiotensin II (Ang I
I) infusion for 14 days mimics two-kidney, one clip Goldblatt hyperten
sion and increases intrarenal Ang II levels. The objective of the pres
ent study was to determine whether the augmented intrarenal Ang II is
due to intrarenal accumulation of the infused Ang II and/or to an incr
ease in intrarenal formation of endogenous Ang II. Male Sprague-Dawley
rats were uninephrectomized and divided into three groups: control (n
=6), those infused with [Ile(5)]Ang II (endogenous form) (n=6), and th
ose infused with [Val(5)]Ang II (n=8). [Ile(5)]Ang II or [Val(5)]Ang I
I was infused at 40 ng/min via an osmotic minipump implanted subcutane
ously. By day 12, systolic blood pressure increased significantly in b
oth [Val(5)]Ang II-infused rats (197+/-7 mm Hg) and [Ile(5)]Ang II-inf
used rats (173+/-3 mm Hg). Blood and kidney samples were harvested, su
bjected to high-performance liquid chromatography to separate [Val(5)]
Ang II from [Ile(5)]Ang II, and then measured by radioimmunoassay. Pla
sma renin activity was markedly suppressed in both [Ile(5)]Ang II- and
[Val(5)]Ang II-infused rats. Plasma Ang II levels were elevated in ra
ts infused with both [Ile(5)]Ang II (121+/-24 fmol/mL) and [Val(5)]Ang
II (119+/-14 fmol/mL) compared with controls (69+/-15 fmol/mL). Both
[Ile(5)]Ang II- and [Val(5)]Ang II-infused rats exhibited an enhanceme
nt of total intrarenal Ang II. Only [Ile(5)]Ang II (358+/-53 fmol/g) w
as detected in the kidneys of rats infused with [Ile(5)]Ang II. In [Va
l(5)]Ang II-infused rats, a significant portion of total renal Ang II
(371+/-57 fmol/g) was in the form of [Val(5)]Ang II (256+/-44 fmol/g).
Renal [Ile(5)]Ang II levels were maintained in the [Val(5)]Ang II-inf
used rats (116+/-15 fmol/g) compared with control rats (116+/-11 fmol/
g) despite marked suppression of renin release. These results support
the hypothesis that infused circulating Ang II is bound to receptor or
taken up intrarenally in a manner that protects against degradation.